BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawasaki Y, Ishigami S, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, Kita Y, Nishizono Y, Okumura H, Nakajo A, Kijima Y, Maemura K, Natsugoe S. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer. BMC Cancer. 2015;15:5. [PMID: 25588809 DOI: 10.1186/s12885-015-1008-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Osman NATAG, Abd El-Maqsoud NMR, El Gelany SAA. Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary). World J Oncol 2015;6:364-74. [PMID: 28983331 DOI: 10.14740/wjon931w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Monastra G, De Grazia S, Cilaker Micili S, Goker A, Unfer V. Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage. Expert Opinion on Drug Delivery 2016;13:1695-708. [DOI: 10.1080/17425247.2016.1200556] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
3 Yue CF, Li LS, Ai L, Deng JK, Guo YM. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2. Exp Cell Res 2021;402:112553. [PMID: 33737068 DOI: 10.1016/j.yexcr.2021.112553] [Reference Citation Analysis]
4 Minaei A, Sabzichi M, Ramezani F, Hamishehkar H, Samadi N. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol Biol Rep 2016;43:99-105. [DOI: 10.1007/s11033-016-3942-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 8.2] [Reference Citation Analysis]
5 Garufi A, Giorno E, Gilardini Montani MS, Pistritto G, Crispini A, Cirone M, D'Orazi G. P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex. Biomolecules 2021;11:348. [PMID: 33669070 DOI: 10.3390/biom11030348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kitamura H, Motohashi H. NRF2 addiction in cancer cells. Cancer Sci. 2018;109:900-911. [PMID: 29450944 DOI: 10.1111/cas.13537] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 24.5] [Reference Citation Analysis]
7 Wang L, Zhang C, Qin L, Xu J, Li X, Wang W, Kong L, Zhou T, Li X. The prognostic value of NRF2 in solid tumor patients: a meta-analysis. Oncotarget 2018;9:1257-65. [PMID: 29416692 DOI: 10.18632/oncotarget.19838] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
8 Guo Q, Jing FJ, Qu HJ, Xu W, Han B, Xing XM, Ji HY, Jing FB. Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins. Biomed Res Int 2019;2019:4390839. [PMID: 30915355 DOI: 10.1155/2019/4390839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhao Y, Sun Y, Wang G, Ge S, Liu H. Dendrobium Officinale Polysaccharides Protect against MNNG-Induced PLGC in Rats via Activating the NRF2 and Antioxidant Enzymes HO-1 and NQO-1. Oxid Med Cell Longev 2019;2019:9310245. [PMID: 31281597 DOI: 10.1155/2019/9310245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ahmed SMU, Jiang ZN, Zheng ZH, Li Y, Wang XJ, Tang X. AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy. Oncol Lett 2019;17:773-80. [PMID: 30655829 DOI: 10.3892/ol.2018.9705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Panieri E, Saso L. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells. Antioxid Redox Signal 2021;34:1428-83. [PMID: 33403898 DOI: 10.1089/ars.2020.8146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu H, Liu M, He B, Li Q. Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways. Clin Res Hepatol Gastroenterol 2021;:101779. [PMID: 34332125 DOI: 10.1016/j.clinre.2021.101779] [Reference Citation Analysis]
13 Xu Y, Yang Y, Huang Y, Ma Q, Shang J, Guo J, Cao X, Wang X, Li M. Inhibition of Nrf2/HO-1 signaling pathway by Dextran Sulfate suppresses angiogenesis of Gastric Cancer. J Cancer 2021;12:1042-60. [PMID: 33442403 DOI: 10.7150/jca.50605] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Jeddi F, Soozangar N, Sadeghi MR, Somi MH, Shirmohamadi M, Eftekhar-Sadat AT, Samadi N. Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer. Biomed Pharmacother 2018;97:286-92. [PMID: 29091877 DOI: 10.1016/j.biopha.2017.10.129] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
15 Jaganjac M, Milkovic L, Sunjic SB, Zarkovic N. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. Antioxidants (Basel) 2020;9:E1151. [PMID: 33228209 DOI: 10.3390/antiox9111151] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
16 Ma JQ, Tuersun H, Jiao SJ, Zheng JH, Xiao JB, Hasim A. Functional Role of NRF2 in Cervical Carcinogenesis. PLoS One 2015;10:e0133876. [PMID: 26247201 DOI: 10.1371/journal.pone.0133876] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
17 Stading R, Gastelum G, Chu C, Jiang W, Moorthy B. Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer. Semin Cancer Biol 2021:S1044-579X(21)00195-4. [PMID: 34242741 DOI: 10.1016/j.semcancer.2021.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kinowaki Y, Taguchi T, Onishi I, Kirimura S, Kitagawa M, Yamamoto K. Overview of Ferroptosis and Synthetic Lethality Strategies. Int J Mol Sci 2021;22:9271. [PMID: 34502181 DOI: 10.3390/ijms22179271] [Reference Citation Analysis]
19 Wu Z, Hui J. Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway. J Gastrointest Oncol 2020;11:1242-52. [PMID: 33456997 DOI: 10.21037/jgo-20-406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Luo D, Yang Q, Wang H, Tan M, Zou Y, Liu J. A predictive model for assessing prognostic risks in gastric cancer patients using gene expression and methylation data. BMC Med Genomics 2021;14:14. [PMID: 33407483 DOI: 10.1186/s12920-020-00856-0] [Reference Citation Analysis]
21 Yi X, Zhao Y, Xue L, Zhang J, Qiao Y, Jin Q, Li H. Expression of Keap1 and Nrf2 in diffuse large B-cell lymphoma and its clinical significance. Exp Ther Med 2018;16:573-8. [PMID: 30112024 DOI: 10.3892/etm.2018.6208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Robertson H, Dinkova-Kostova AT, Hayes JD. NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis. Cancers (Basel) 2020;12:E3609. [PMID: 33276631 DOI: 10.3390/cancers12123609] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
23 Tong YH, Zhang B, Yan YY, Fan Y, Yu JW, Kong SS, Zhang D, Fang L, Su D, Lin NM. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer. Oncotarget 2017;8:45750-8. [PMID: 28501854 DOI: 10.18632/oncotarget.17403] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
24 Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG, Berindan-Neagoe I. The Role of Nrf2 Activity in Cancer Development and Progression. Cancers (Basel). 2019;11. [PMID: 31717324 DOI: 10.3390/cancers11111755] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 17.0] [Reference Citation Analysis]
25 Beury DW, Carter KA, Nelson C, Sinha P, Hanson E, Nyandjo M, Fitzgerald PJ, Majeed A, Wali N, Ostrand-Rosenberg S. Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2. J Immunol 2016;196:3470-8. [PMID: 26936880 DOI: 10.4049/jimmunol.1501785] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 8.3] [Reference Citation Analysis]
26 Hafez AM, Harb OA, Alattar AZ, Hefzi N, Ahmed RZ, Shaker SE, Ibrahim A, El-Taher AK. Clinico-pathological and prognostic implications of Srx, Nrf2, and PROX1 expression in gastric cancer and adjacent non-neoplastic mucosa - an immunohistochemical study. Contemp Oncol (Pozn) 2020;24:229-40. [PMID: 33531870 DOI: 10.5114/wo.2020.102671] [Reference Citation Analysis]
27 Zevallos JP, Mazul AL, Walter V, Hayes DN. Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer. Laryngoscope 2019;129:154-61. [PMID: 30247749 DOI: 10.1002/lary.27340] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Bai X, Chen Y, Hou X, Huang M, Jin J. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. Drug Metab Rev 2016;48:541-67. [PMID: 27320238 DOI: 10.1080/03602532.2016.1197239] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 13.0] [Reference Citation Analysis]
29 Kong Q, Deng H, Li C, Wang X, Shimoda Y, Tao S, Kato K, Zhang J, Yamanaka K, An Y. Sustained high expression of NRF2 and its target genes induces dysregulation of cellular proliferation and apoptosis is associated with arsenite-induced malignant transformation of human bronchial epithelial cells. Science of The Total Environment 2021;756:143840. [DOI: 10.1016/j.scitotenv.2020.143840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Telkoparan-Akillilar P, Suzen S, Saso L. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs. Int J Mol Sci 2019;20:E2025. [PMID: 31022969 DOI: 10.3390/ijms20082025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
31 Baird L, Yamamoto M. NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer. Mol Cell Biol 2021;41:e00473-20. [PMID: 33139492 DOI: 10.1128/MCB.00473-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
32 Sheth S, Farquhar DR, Schrank TP, Stepp W, Mazul A, Hayward M, Lenze N, Little P, Jo H, Major MB, Chera BS, Zevallos JP, Hayes DN. Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma. Laryngoscope Investig Otolaryngol 2021;6:699-707. [PMID: 34401494 DOI: 10.1002/lio2.588] [Reference Citation Analysis]
33 Jiapaer S, Furuta T, Tanaka S, Kitabayashi T, Nakada M. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma. Neurol Med Chir (Tokyo) 2018;58:405-21. [PMID: 30249919 DOI: 10.2176/nmc.ra.2018-0141] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 22.0] [Reference Citation Analysis]
34 Han M, Li N, Li F, Wang H, Ma L. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2. Hum Cell 2020;33:641-51. [PMID: 32419118 DOI: 10.1007/s13577-020-00329-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Chen J, Yu Y, Ji T, Ma R, Chen M, Li G, Li F, Ding Q, Kang Q, Huang D, Liang X, Lin H, Cai X. Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma. Cancer Med 2016;5:2678-87. [PMID: 27650414 DOI: 10.1002/cam4.788] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
36 Nukui A, Narimatsu T, Kambara T, Abe H, Sakamoto S, Yoshida KI, Kamai T. Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer. BMC Cancer 2018;18:493. [PMID: 29716554 DOI: 10.1186/s12885-018-4427-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
37 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]